Time to secondary resistance (TSR) after interruption of imatinib (IM) in advanced GIST: Updated results of the prospective French Sarcoma Group randomized phase III trial on long-term survival. This ...

Esophageal cancer remains one of the world's deadliest cancers, ranking 7th in incidence and 6th in cancer-related deaths ...

According to the 2022 national cancer registration statistics, the number of gastric cancer patients was 356,507, accounting ...

The median tumor size was 10.7 cm (range, 1.7-35 cm). Most patients with GIST (51%) had their primary disease located in the stomach followed by small intestine, including both duodenum and jejunum, ...

In the United States, approximately 55% of resected gallbladder cancer (GBC) patients undergo oncologic surgery without ...